Skip to content
healthcare.dev

OPSUMIT

NDC 66215-501, macitentan, tablet, film coated, from Actelion Pharmaceuticals US, Inc..

Product NDC
66215-501
Status
Listed
Labeler
Actelion Pharmaceuticals US, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA204410
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/66215-501 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MACITENTAN10 mg/1

Pharmacologic classes

Endothelin Receptor Antagonist [EPC]; Endothelin Receptor Antagonists [MoA]

Package NDCNDC-11Package
66215-501-15662150501151 BLISTER PACK in 1 CARTON (66215-501-15) / 15 TABLET, FILM COATED in 1 BLISTER PACK
66215-501-30662150501301 BOTTLE in 1 CARTON (66215-501-30) / 30 TABLET, FILM COATED in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1e484a50-55db-4b85-8c57-6cd1b0353abd

Use it

Look up 66215-501 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/66215-501 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 66215-501. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.